Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00529581 | A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis | PHASE2 | COMPLETED | 150 | — | — | Nov 1, 2006 | Apr 1, 2008 | May 28, 2008 | 30 | United States |
| Name | Type | Description |
|---|---|---|
| C105 | DRUG | - |
Inclusion Criteria: * Males/females at least 18 years old and \< 65 years old, capable of understanding and complying with the protocol, including speaking and writing fluent English and having at least a 9th grade education * Clinically definite diagnosis per McDonald criteria of Multiple Sclerosi...